Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.

Smoot K, Chen C, Stuchiner T, Lucas L, Grote L, Cohan S

Open source

DOI
10.1136/bmjno-2020-000108
Published
2021
Container
BMJ neurology open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjno-2020-000108,
  title = {Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.},
  author = {Smoot K and Chen C and Stuchiner T and Lucas L and Grote L and Cohan S},
  year = {2021},
  journal = {BMJ neurology open},
  doi = {10.1136/bmjno-2020-000108},
  url = {https://doi.org/10.1136/bmjno-2020-000108}
}

RIS

TY  - JOUR
TI  - Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.
AU  - Smoot K
AU  - Chen C
AU  - Stuchiner T
AU  - Lucas L
AU  - Grote L
AU  - Cohan S
PY  - 2021
JO  - BMJ neurology open
DO  - 10.1136/bmjno-2020-000108
UR  - https://doi.org/10.1136/bmjno-2020-000108
ER  - 

APA

K, S., C, C., T, S., L, L., L, G., & S, C. (2021). Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.. BMJ neurology open. https://doi.org/10.1136/bmjno-2020-000108

Source records